ContributorsPublishersAdvertisers

Gene Therapy Redosing Gains Traction as Need Grows and Novel Strategies Emerge

biospace.com
 2021-10-20

Cover picture for the articleSelecta President and CEO Carsten Brunn, Ph.D./Courtesy Selecta BioSciences. Gene therapy is often thought of as a one-time-only treatment, but for non-integrating therapies (which don’t alter the genes or integrate into the genome) the results aren’t always durable. Redosing, consequently, is a large and growing concern for gene therapy developers and...

www.biospace.com

Comments / 0

Comments / 0